Further experiments included an MCF-7 xenograft model and revealed that mortalin promotes EMT and maintains breast cancer stemness via activation of the Wnt/glycogen synthase kinase-3β (GSK3β)/β-catenin signaling pathway in vivo and in vitro [34]. Here, HSPA9 is linked to breast carcinoma.